Exothera Expands World-First Continuous-Batch RNA Manufacturing Solution to North America to Accelerate RNA Therapies

Game-changing continuous-batch production of RNA service removes process development and scale-up steps through automation and significantly cuts clinical ...

March 27, 2024 | Wednesday | News
Croda International Plc and AAHI Partner to Advance Global Access to Next-Generation Vaccine Adjuvants

Croda International Plc (Croda) and The Access to Advanced Health Institute (AAHI) are pleased to announce the signing of a partnership agreement around in...

March 21, 2024 | Thursday | News
Special Spotlight Report: GSK's COiMMUNITY Initiative Boosts Adult Vaccination Rates

  Rob Truckenmiller, Senior Vice President, Head of US Vaccines, GSK, emphasized the importance of collaborative efforts and fi...

March 08, 2024 | Friday | Reports
Takeda and Biological E. Limited Partner to Enhance Dengue Vaccine Availability in High-Risk Regions

Biological E. Limited (BE) to Manufacture Up to 50 Million Doses of QDENGA Per Year, Accelerating Takeda’s Ability to Deliver 100 Million Doses Per...

February 27, 2024 | Tuesday | News
LimmaTech Biologics Announces Positive Interim Results for Shigella4V Vaccine in Phase I/II Trial

LimmaTech Biologics AG, announced encouraging interim results from its Phase I/II clinical trial evaluating Shigella4V (S4V), a promising tetravalent bioco...

February 22, 2024 | Thursday | News
Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology

  In a bold move, Vaccinex has forged eight new antibody discovery agreements with leading pharmaceutical and biotechnology companies, as well as str...

February 21, 2024 | Wednesday | News
Ultimovacs' UV1 Cancer Vaccine Granted EMA Orphan Drug Designation for Mesothelioma Treatment

Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology leader in novel immunotherapeutic cancer vaccines,  announced tha...

February 19, 2024 | Monday | News
Medidata and Sanofi Vaccines Forge Deeper Collaboration to Enhance Patient Centricity and Trial Efficiency

Medidata, a Dassault Systèmes company and a leading provider of clinical trial solutions to the life sciences industry, has joined forces with Sanof...

February 07, 2024 | Wednesday | News
Valneva Begins Pediatric Trial for Single-Shot Chikungunya Vaccine

The Company reported positive pivotal Phase 3 data in adolescents two months ago confirming the immunogenicity and safety profile observed in adults1.There...

January 10, 2024 | Wednesday | News
Omniose Joins Forces with AstraZeneca for Breakthrough Research on Vaccines for Severe Bacterial Diseases

Omniose, a preclinical stage biotechnology company, today announced an exclusive collaboration agreement with AstraZeneca for the search for potential vacc...

January 08, 2024 | Monday | News
Curevo Vaccine Triumphs in Phase 2 Trial: Amezosvatein Beats Shingrix in Shingles Showdown!

- Positive data from 876-patient head-to-head trial versus Shingrix® shows amezosvatein met the primary immunogenicity endpoint, eliciting a robust imm...

January 08, 2024 | Monday | News
Vaccines Eligible for WHO Prequalification: Unveiling the Vaccines Prequalification Priority List 2024 - 2026

The priority categorization, established by the WHO in collaboration with UNICEF and the Revolving Fund of the Pan American Health Organization, is based o...

January 04, 2024 | Thursday | News
Sail Biomedicines Secures Grants for RNA Medicines Against Malaria

-Sail Biomedicines, Inc. (“Sail” or the “Company”), a Flagship Pioneering company and leader in RNA-based programmable medicines, a...

January 04, 2024 | Thursday | News
BioNTech Hits Milestone with mRNA Vaccine Facility in Rwanda

Set-up of first BioNTainer as high-tech manufacturing solution for mRNA medicines is a critical step in establishing a resilient vaccine ecosystem in Afr...

December 19, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in